{"id":"W2899608945","doi":"10.1016/s2213-2600(18)30406-5","title":"Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Francophone University Association; Vancouver General Hospital; University of British Columbia","funders":"Kyowa Hakko Kirin; Pearl Therapeutics; AstraZeneca","keywords":"Benralizumab; Medicine; Placebo; Tolerability; Clinical endpoint; Internal medicine; Adverse effect; Asthma; Clinical trial; Dosing; Mepolizumab; Eosinophil; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004583661,0.001242582,0.003469058,0.0002033267,0.0006334782,0.001980804,0.0008827636,0.002018456,0.002027008],"category_scores_gemma":[0.003225653,0.0005676632,0.004387922,0.0003217551,0.001069155,0.001304717,0.0005699878,0.004603024,0.000660534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009574946,"about_ca_system_score_gemma":0.001108082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001580157,"about_ca_topic_score_gemma":0.002407805,"domain_scores_codex":[0.998326,0.0008630694,0.00009045324,0.0002418862,0.0001415763,0.0003369436],"domain_scores_gemma":[0.9970631,0.0009770076,0.0007230977,0.0003686093,0.0001835214,0.0006846079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9468983,0.003630524,0.01316112,0.0006587746,0.004611784,0.000116563,0.0001485791,0.0007597682,0.004375931,0.0001267225,0.001750767,0.02376114],"study_design_scores_gemma":[0.7891685,0.1053704,0.09507841,0.0001714377,0.00475347,0.0002539079,0.0001525159,0.0007204209,0.000997992,0.0004250524,0.002823292,0.00008462851],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840224,0.01224298,0.0002049279,0.000786242,0.0002369257,0.0002007306,0.001193937,0.00003379952,0.001077978],"genre_scores_gemma":[0.9934844,0.002101423,0.000262309,0.0009450566,0.0002814787,0.0002379246,0.001790184,0.00001615665,0.0008810756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004583661,"threshold_uncertainty_score":0.02424097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02642157700709075,"score_gpt":0.3072804654897434,"score_spread":0.2808588884826526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}